ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
抗疫概念
878.789
-11.619
-1.30%
手動刷新
漲家數:
3
跌家數:
14
平家數:
- -
市盈率:
- -
高:
889.460
開:
889.460
低:
870.070
收:
890.408
成交量:
3.01億
成交額:
22.54億
市值:
5,928.82億
流通市值:
4,916.77億
資料載入中...
總覽
新聞
大行評級丨星展:上調比亞迪電子目標價至40港元,維持「買入」評級
格隆汇
·
09/04
港股異動 | 四環醫藥(00460)午前漲近4% 軒竹生物與INNOBIC就吡洛西利於泰國市場達成商業化合作
智通财经
·
09/04
連虧7年半股迪哲醫藥董事長擬減持 A股募資39億零派息
中金财经
·
09/04
中生製藥(01177.HK)GPC3 ADC臨床試驗申請獲FDA批准
阿斯达克财经
·
09/04
【券商聚焦】交銀國際:醫藥行業收入穩健增長 多重利好推動盈利表現顯著改善
金吾财讯
·
09/04
勁方醫藥-B(02595)存倉市值總計19.55億港元 股東將4373.09萬股股票存入渣打銀行(香港)
智通财经
·
09/04
醫藥代表退場,基藥目錄「及時雨」能否解藥企之渴?
蓝鲸财经
·
09/03
白雲山:2026年半年度權益分派實施公告
证券日报网
·
09/03
九州通與京東健康簽署戰略合作協議
南方财经网
·
09/03
王磊增持華潤萬象生活(01209)5萬股 每股作價38.52港元
智通财经
·
09/03
勁方醫藥-B(02595)9月3日斥資54.64萬港元回購2萬股
智通财经
·
09/03
白雲山:每股派0.30元,股權登記日為9月9日
南方财经网
·
09/03
貝萊德在國藥控股的H股好倉比例下降0.18%至8.93%
南方财经网
·
09/03
復星醫藥(02196.HK):蘆沃美替尼片新增適應症獲註冊批准
智通财经
·
09/03
復星醫藥(600196.SH)子公司蘆沃美替尼片新增適應症獲註冊批准
智通财经
·
09/03
港股異動 | 同源康醫藥-B(02410)午後升逾9% EGFR-TKI氘申艾替尼獲批一線治療晚期非小細胞肺癌
智通财经
·
09/03
大行評級丨高盛:下調歌禮制藥目標價至13.86港元,維持「中性」評級
格隆汇
·
09/03
同仁堂科技:營銷體系再升級 品種全生命周期管理提質增效
证券日报
·
09/03
《半日速報》恒指半日收報25,317點 升6點; 恒生科技指數半日收報4,491點 跌25點 平安升逾3% 小米集團跌逾3% 卓越睿新、德翔海運、TCL電子創新高
阿斯达克财经
·
09/03
星展銀行上調比亞迪電子目標價至40港元
格隆汇
·
09/03
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BK1515/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":878.7892,"timestamp":1789114133774,"preClose":890.4082,"halted":0,"volume":300625831,"delay":0,"changeRate":-0.013049,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-11.619019,"latestTime":"09-11 16:00:00","open":889.45984,"high":889.45984,"low":870.06995,"amount":2253603899,"amplitude":0.021776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.318473,"peRate":17.086203,"turnoverRate":0.003644,"increases":3,"decrements":14,"flats":0,"marketCap":592881820352,"floatMarketCap":491676687872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":889.45984,"amplitude":0.021776,"preClose":890.4082,"low":870.06995,"pbRate":"1.318473","latestPrice":878.7892,"volume":300625831,"delay":0,"open":889.45984,"prevYearClose":1190.107,"prevWeekClose":936.431,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":936.431,"twentyDayClose":912.416,"sixtyDayClose":852.523,"secType":"PLATE","market":"HK","turnoverRate":0.003644,"peRate":17.086203,"marketCap":592881820352,"floatMarketCap":491676687872,"timestamp":1789114133774,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":3,"down":14,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664038995","title":"大行評級丨星展:上調比亞迪電子目標價至40港元,維持「買入」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664038995","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664038995?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 13:14","pubTimestamp":1788498884,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["00285","BK1580","BK1515","LU0348767384.USD","BK1607","BK1589","BK1582","BK1149","LU0348766576.USD","LU0274383008.USD","BK1504","BK1167","BK1540"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386607","title":"港股異動 | 四環醫藥(00460)午前漲近4% 軒竹生物與INNOBIC就吡洛西利於泰國市場達成商業化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386607","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386607?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 11:52","pubTimestamp":1788493955,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,四环医药午前涨近4%,截至发稿,涨3.92%,报0.795港元,成交额981.3万港元。Innobic(亚洲)将作为经销商,负责目标产品于目标区域的药品注册、本地市场营销及商业化运营。轩竹生物将按约定供货价格供应目标产品,以支持目标产品在目标区域的商业化活动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","BK1515","KCAI","BK1593","BK1191","VXUS","02575","BK1600","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664138500","title":"連虧7年半股迪哲醫藥董事長擬減持 A股募資39億零派息","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138500","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138500?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 11:34","pubTimestamp":1788492846,"startTime":"0","endTime":"0","summary":"中国经济网北京9月4日讯 迪哲医药 昨日晚间发布关于董事、高级管理人员减持股份计划公告。 迪哲医药称,上述减持对象本次减持数量占其本人本次减持前所持有公司股份数量均不超过25%。 截至减持股份计划预披露公告发布前最后一个交易日,即2026年9月3日,迪哲医药收报60.08元,以此计算,上述减持主体本次减持金额合计预计为2.17亿元。 经计算,迪哲医药上述两次募集资金金额合计为38.99亿元。 迪哲医药自上市以来未分红。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260904/32360003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02846","83188","BK1574","83130","BK1515","VIG","399300","09939","BK4585","02827","159938","BK4588","07233","03130","82846","BK1147","03188","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664241388","title":"中生製藥(01177.HK)GPC3 ADC臨床試驗申請獲FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664241388","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664241388?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:24","pubTimestamp":1788485040,"startTime":"0","endTime":"0","summary":"中国生物制药(01177.HK) 公布,集团附属公司正大天晴自主研发的国家1类新药TQB6426“GPC3抗体药物偶联物(ADC)”已获得美国食品药品监督管理局(FDA)的新药临床试验(IND)批准,拟用于晚期恶性肿瘤。目前,全球尚无靶向GPC3的ADC药物获批上市,同类候选产品整体处于临床前及早期临床探索阶段。集团将加速TQB6426的I期临床试验,评估其在晚期恶性肿瘤患者中的安全性、耐受性、药代动力学特征及初步疗效,尽早为全球肝细胞癌及更多实体瘤患者提供新的治疗选择。(sl/a)(港股报价延迟最少十五分钟。沽空资料截至 2026-09-03 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542877/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542877/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01177","BK1574","BK1515","IE00BZ08YT58.USD","BK1191","BK1521","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1589","01477","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238859","title":"【券商聚焦】交銀國際:醫藥行業收入穩健增長 多重利好推動盈利表現顯著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238859","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664238859?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:00","pubTimestamp":1788483634,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示,1H26港股/A股医药行业整体收入增长4.7%/3.2%。创新药产业链增速领跑行业,服务板块复苏:1)港股/A股CXO收入整体增长29.2%/25.3%,(扣非)净利润增长23.4%/67.6%,在各子板块中增速最快,行业整体景气度和订单需求处于高位。2)核心成药板块收入增长17.8%/3.4%、利润增长62.7%/35.0%。其中生物药增速远超化药,在板块收入中的占比也进一步提升。3)医院、器械、诊断、疫苗等板块业绩有复苏趋势。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990646","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0327786744.USD","02273","03692","06078","09966","06821","BK1209","KURE","LU0307460666.USD","02268","03759","LU0856984785.SGD","KCE","BK1589","IE00B5MMRT66.SGD","LU1242518857.USD","01548","02096","03329","02269","IE00B543WZ88.USD","LU1880383366.USD","00013","BK1161","IE00B0JY6N72.USD","06996","06160","LU1152091168.USD","BK1515","HK0000306685.HKD","01093","01801","LU2543165471.USD","LU1251922891.USD","LU0315179316.USD","01530","09926","06990","HK0000320264.USD","09996","LU0588546209.SGD","01177","02596","01952","LU0348783233.USD","01276","SG9999004220.SGD","LU0039217434.USD","01951","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388377","title":"勁方醫藥-B(02595)存倉市值總計19.55億港元 股東將4373.09萬股股票存入渣打銀行(香港)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388377","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388377?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 08:34","pubTimestamp":1788482051,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,9月3日,劲方医药-B(02595)出现存仓异动,存仓市值总计19.55亿港元,占比19.65%。该公司股东将4373.09万股股票存入渣打银行(香港),持股比例增加12.44%。劲方医药此前发布公告,GFH375已进入一线治疗KRAS G12D突变型晚期非小细胞肺癌(NSCLC)的II期研究,包括单药疗法、联合EGFR单抗(西妥昔单抗)或联合化疗(培美曲塞)三种治疗方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1574","09939","BK1161","02595","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803502","title":"醫藥代表退場,基藥目錄「及時雨」能否解藥企之渴?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803502","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803502?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 23:41","pubTimestamp":1788450086,"startTime":"0","endTime":"0","summary":"02 8年磨一剑,基药目录送来“及时雨”恰在此时,基药目录更新了。二是基药目录首次纳入创新药。集采中标、医保谈判、基药目录入围构成了药品放量的三大政策通道。白马认为,基药目录的“及时雨”能解药企一时之渴,却解不了长期之渴。当医药代表退场的尘埃落定,当“带金销售”彻底成为过去式,真正能笑到最后的,是那些产品过硬、证据扎实、推广合规的药企。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788329362059116704","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1161","BK1515","09939","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083968","title":"白雲山:2026年半年度權益分派實施公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083968","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664083968?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:32","pubTimestamp":1788442320,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月3日,白云山发布2026年半年度权益分派实施公告称,本次利润分配以方案实施前的公司总股本1,625,790,949股为基数,每股派发现金红利0.30元(含税),共计派发现金红利487,737,284.70元(含税)。股权登记日为2026年9月9日,除权(息)日为2026年9月10日。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-03/doc-iniqqfvs6793255.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-03/doc-iniqqfvs6793255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0196","BK0028","BK0183","BK0096","BK0175","BK0188","BK1191","BK0070","BK1197","BK1606","BK0012","BK1521","BK0239","600332","00874","BK1515","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874372","title":"九州通與京東健康簽署戰略合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874372","media":"南方财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874372?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 20:09","pubTimestamp":1788437340,"startTime":"0","endTime":"0","summary":"南方财经9月3日电,据九州通医药集团消息,9月3日,九州通医药集团(简称“九州通”)与京东健康签署战略合作协议。双方将共同整合渠道、供应链、技术与金融服务等领域的核心优势,围绕供应链、履约、消费场景与数智化采购等场景进行多维度深化协同,不断探索新模式、优化产业链效率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864255516.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864255516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","BK1591","600998","BK1571","BK1589","BK0039","BK1583","BK0183","BK1515","LU0051755006.USD","BK0196","BK0028","BK0012","BK1615","LU0456827905.SGD","BK0146","86618","BK1247","BK0201","BK0097","SGXZ86797644.SGD","BK0187","BK0077","SGXZ62798434.SGD","BK1142","06618","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664787979","title":"王磊增持華潤萬象生活(01209)5萬股 每股作價38.52港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664787979","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664787979?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 19:30","pubTimestamp":1788435038,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,9月1日,王磊增持华润万象生活(01209)5万股,每股作价38.52港元,总金额为192.6万港元。增持后最新持股数目约为5万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1615","BK1247","BK1501","BK1571","BK1502","BK1584","BK1583","LU0082770016.SGD","01209","BK1515","BK1617","BK1589","LU0082770016.USD","BK1258","BK1542","BK1610","BK1142","BK1229","00241","LU0164939612.USD","BK1591","LU0456846285.SGD","BK1189","LU0620787316.HKD","LU0051755006.USD","HK0000165453.HKD","EWH","LU0456827905.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664879974","title":"勁方醫藥-B(02595)9月3日斥資54.64萬港元回購2萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664879974","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664879974?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 19:21","pubTimestamp":1788434461,"startTime":"0","endTime":"0","summary":"智通财经APP讯,劲方医药-B(02595)发布公告,于2026年9月3日斥资54.64万港元回购2万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491703.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","159938","02595","BK1161","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875081","title":"白雲山:每股派0.30元,股權登記日為9月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875081","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875081?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 18:15","pubTimestamp":1788430500,"startTime":"0","endTime":"0","summary":"南财智讯9月3日电,白云山发布2026年半年度权益分派实施公告,每股派0.30元(含税),股权登记日为9月9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864171782.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864171782.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0097","BK0028","BK0070","BK0183","BK0196","BK0239","BK1191","00874","BK0175","BK1197","BK1515","BK0012","BK0096","600332","BK0188","BK1606","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878268","title":"貝萊德在國藥控股的H股好倉比例下降0.18%至8.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878268","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878268?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:24","pubTimestamp":1788427440,"startTime":"0","endTime":"0","summary":"南财智讯9月3日电,香港交易所披露信息显示,BlackRock,Inc.(贝莱德)在国药控股的H股好仓(L)比例于8月31日从9.11%下降至8.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864136039.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864136039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","01099","BK1197","LU1115378108.SGD","LU0640798160.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664781028","title":"復星醫藥(02196.HK):蘆沃美替尼片新增適應症獲註冊批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664781028","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664781028?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:22","pubTimestamp":1788427355,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02196","BK1515","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664264827","title":"復星醫藥(600196.SH)子公司蘆沃美替尼片新增適應症獲註冊批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664264827","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664264827?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:21","pubTimestamp":1788423715,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复星医药(600196.SH)发布公告,近日,公司控股子公司上海复星医药产业发展有限公司就芦沃美替尼片(商品名:复迈宁、项目代号:FCN-159)新增适应症的药品注册申请获国家药品监督管理局批准,本次获批的新适应症为用于伴有症状、无法手术的丛状神经纤维瘤(PN)的I型神经纤维瘤病(NF1)成人患者。该药品为集团自主研发的创新型小分子化学药物,为MEK1/2选择性抑制剂。本次新增适应症获批,可为中国境内相关罕见肿瘤患者提供新的治疗选择,并进一步增强该药品的市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0175","600196","BK0183","BK1515","BK0060","BK1191","BK1593","BK0196","BK0188","BK0028","BK0187","BK0096","02196","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664824858","title":"港股異動 | 同源康醫藥-B(02410)午後升逾9% EGFR-TKI氘申艾替尼獲批一線治療晚期非小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664824858","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664824858?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 14:30","pubTimestamp":1788417020,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,同源康医药-B午后涨超9%。消息面上,同源康医药近日宣布,公司自主研发的新一代EGFR-TKI创新药甲磺酸氘申艾替尼片已正式获得中国国家药品监督管理局批准附条件上市,适应症为具有表皮生长因子受体外显子19缺失或外显子21置换突变,并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌成人患者的一线治疗。同源康预计收取7亿元人民币现金首付款及股份认购款,以及最高20.6亿元人民币的注册里程碑付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","02410","09939","BK1161","VXUS","BK1515","KCAI","BK4585","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664014829","title":"大行評級丨高盛:下調歌禮制藥目標價至13.86港元,維持「中性」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664014829","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664014829?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 14:04","pubTimestamp":1788415446,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1191","BK1574","BK1515","BK1161","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664826791","title":"同仁堂科技:營銷體系再升級 品種全生命周期管理提質增效","url":"https://stock-news.laohu8.com/highlight/detail?id=2664826791","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664826791?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 12:35","pubTimestamp":1788410100,"startTime":"0","endTime":"0","summary":"变局求生,变局图强。2026年上半年,面对中成药行业流通渠道的深刻变革,北京同仁堂科技发展股份有限公司(以下简称“同仁堂科技”)正式启动“品种全周期管理体系”建设,构建从生产端至销售端的一体化链条,在渠道变局中展现出经营韧性与增长质量。“对市场的反应更灵敏、对客户的需求响应更及时、对终端的赋能更有针对性。最终,就是让对的产品,在对的时间,由合适的合作伙伴,最终送到消费者手中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033863901269.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033863901269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1515","BK1606","BK1191","01666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664282653","title":"《半日速報》恒指半日收報25,317點 升6點; 恒生科技指數半日收報4,491點 跌25點 平安升逾3% 小米集團跌逾3% 卓越睿新、德翔海運、TCL電子創新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2664282653","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664282653?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 12:12","pubTimestamp":1788408720,"startTime":"0","endTime":"0","summary":"恒指半日收25,317点,升6点或0.0%。恒生科技指数报4,491点,跌25点或0.6%。国指跌27点或0.3%,报8,423点。沽空资料截至 2026-09-02 16:25。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542745/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542745/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2226246903.HKD","IE00BVYPNP33.GBP","LU1956131251.USD","EMC","LU2125910500.SGD","BK1095","LU2237443622.USD","LU0164939612.USD","LU1813983027.USD","LU0702159699.USD","IE00B19Z5X02.USD","JADE","LU0370786039.SGD","LU2153591404.USD","LU0608807433.USD","LU0082770016.USD","LU1046422090.SGD","LU1008478684.HKD","LU0348766576.USD","LU0516422440.USD","LU1328277881.USD","BK1607","SGXZ62798434.SGD","IE00BMPRXN33.USD","XSOE","LU2152927971.USD","BK1249","01378","LU0192582467.USD","LU0132412106.USD","LU1961090484.USD","KWEB","LU0865486749.SGD","01070","LU1733274473.HKD","LU3063872942.SGD","LU0169518387.USD","SG9999017495.SGD","LU1808992512.USD","LU0315178854.USD","LU0456827905.SGD","IE0032431581.USD","IE00BF5LJ272.USD","LU1282651121.HKD","SG9999002562.SGD","01177","LU1522347837.USD","SG9999000459.SGD","LU0890818403.SGD","LU0868486357.SGD","BK1574","LU0320764755.SGD","LU0737861699.HKD","02687","LU0329678337.USD","LU0828237940.HKD","LU1226287875.USD","LU2088747725.USD","ODDS","LU0972618739.USD","LU2237443549.SGD","LU0315179316.USD","LU1102505762.USD","LU2088748376.SGD","LU0188438112.USD","LU2213484517.USD","SG9999000418.SGD","LU2088748020.USD","LU0607220059.USD","IE00B8L5B284.USD","HK0000306685.HKD","LU0633140560.USD","LU0791590937.USD","LU0577902454.USD","03417","BK1526","LU1048588211.SGD","LU1880398554.USD","03115","LU0061477393.USD","SG9999014880.SGD","LU2462611646.USD","LU0784639295.USD","LU0287142896.SGD","LU0359201885.HKD","LU3227948356.SGD","IE00BZ08YT58.USD","LU1831875114.USD","LU0608807946.USD","LU2097829019.USD","LU2023250504.SGD","LU0251143458.SGD","LU1725190679.HKD","LU0048580855.USD","LU1769817096.USD","LU0708995583.HKD","LU0828238088.HKD","LU2087589342.USD","LU2088748293.HKD","LU0106259558.USD","LU0856984785.SGD","LU0054237671.USD","LU0640798160.USD","01109","BK1575","HBBD.SI","LU0048575426.USD","LU0244354667.USD","LU0348783233.USD","LU0593848301.USD","HK0000352291.HKD","01810","GB00BDT5M118.USD","LU1282651048.USD","SG9999018857.SGD","IE00BWDBJ730.SGD","BK1142","BK1502","LU0516422952.EUR","LU0211977185.USD","LU1196710864.SGD","LU0143863198.USD","LU0648000940.SGD","LU0499858602.USD","DRGN","LU0348816934.USD","BK1190","LU0048388663.USD","LU0049112450.USD","LU1820825898.SGD","SG9999010078.USD","LU1634259557.SGD","LU2247934214.USD","LU1807302812.USD","LU0561508036.HKD","SG9999006597.SGD","LU0823039010.USD","XIACY","LU2362540622.SGD","LU1718418525.SGD","IE00BQXX3F31.USD","IE00B0169L03.USD","IE00B031J352.USD","LU1770034418.SGD","BK1501","BK1521","LU0577902538.SGD","LU1366334578.USD","LU1785774172.SGD","82318","BK1583","BIDD","02318","CRBJY","LU0231483743.USD","LU1152091754.HKD","LU1497733557.USD","SG9999001093.SGD","SG9999004220.SGD","FDNI","LU0261950470.USD","LU2237443382.USD","SG9999014674.SGD","02510","LU0823413587.USD","LU0650527681.SGD","LU2187417386.USD","BK1191","AAXJ","LU0181495838.USD","BK1193","LU0047713382.USD","LU0029874905.USD","LU0210527791.USD","SG9999014898.SGD","SG9999001846.SGD","LU0259732245.USD","LU0130103400.USD","LU2051468812.USD","03032","SG9999000475.SGD","BK1608","LU1720051017.SGD","LU2237443978.SGD","LU1515016050.SGD","LU0314109678.HKD","LU1981816686.USD","LU2148510915.USD","LU0070217475.USD","IE00BQJZWZ67.USD","SG9999015978.USD","LU0348805143.USD","BK1517","BK1588","LU0762542818.HKD","LU0823397103.USD","IE0008369823.USD","LU0594300179.USD","LU1880383440.USD","SG9999002950.SGD","IE0008368742.USD","601939","LU2362541273.HKD","09961","603993","SBHMY","SG9999013353.USD","LU1720051108.HKD","LU0348767384.USD","HK0000288784.HKD","LU1688375341.USD","HXXD.SI","BK1592","CAOVY","07200","LU1226287529.USD","IE00BQXX3C00.GBP","BK1241","IE00B29SXG58.USD","LU0049853897.USD","LU0611395673.USD","SG9999001903.USD","SOCL","513600","LU0648948544.HKD","IE00B031HW06.USD","SG9999001226.SGD","LU0211331839.USD","LU1804176565.USD","601318","SG9999000327.SGD","LU0880133367.SGD","LU1734074674.USD","LU0163747925.USD","LU1211504680.USD","IE00B97KM107.HKD","LU0320764599.SGD","LU0043850808.USD","LU2778985437.USD","09988","09926","HSI","LU1048484197.HKD","LU0128522744.USD","LU0456842615.SGD","81810","HK0000320223.HKD","CXSE","LU0417516738.SGD","LU0572939691.SGD","LU0819121731.USD","IE0001KFT4U8.USD","LU2237443895.HKD","IE00B543WZ88.USD","LU1303224171.USD","LU1439102457.SGD","LU1794554557.SGD","LU2133065610.SGD","LU0577902371.SGD","LU0384037296.USD","SG9999002463.SGD","LU0029875118.USD","ALBmain","LU2008162690.USD","LU0672654166.SGD","LU0630378692.HKD","LU0823413660.USD","LU1769817179.HKD","LU0577902611.USD","LU1282649810.SGD","LU0469268626.HKD","BKF","LU1691799644.USD","LU0589944569.HKD","LU0307460666.USD","TCHI","LU0463099449.HKD","EMCS","IE0034224299.USD","LU0634319403.HKD","LU0651947912.USD","LU1655091459.SGD","IE00B031HY20.USD","TCHmain","03088","BK1515","LU0348783662.USD","LU0196878994.USD","LU1224444064.USD","LU0072913022.USD","LU0164880469.USD","LU0348814723.USD","LU2279701549.SGD","SG9999009443.AUD","LU2097828474.EUR","BK1568","SG9999009997.SGD","IE00BPRC5H50.USD","LU0011963245.USD","LU0165289439.USD","LU0502904849.HKD","SGXZ90724238.SGD","HK0000914686.HKD","LU1366334651.USD","LU0499858438.USD","LU2317271919.USD","LU0203345920.USD","LU0831103253.SGD","LU0414403682.SGD","02600","LU2153592121.USD","HTCD.SI","LU1720050803.USD","LU0821914370.USD","LU1048596156.SGD","LU1951186391.HKD","SG9999014914.USD","LU1974910355.USD","IE0031814852.USD","02255","LU1171460220.USD","BK1513","SGXZ81514606.USD","03033","SG9999011746.SGD","LU2097828805.USD","LU0348735423.USD","LU1282649141.HKD","LU0898667661.SGD","LU0264606111.USD","LU0540923850.HKD","IE00BGHQDM52.EUR","BK1228","LU0197773673.USD","LU1548497426.USD","FFEM","LU1064131003.USD","HPAD.SI","LU0708995153.HKD","LU0831093199.SGD","LU0738912210.USD","LU2257852520.SGD","SG9999001069.SGD","LU0067412154.USD","LU0516422366.SGD","LU1497734951.SGD","LU1917777945.USD","07300","LU1675838814.USD","LU2177674079.SGD","BK1609","LU0700851271.USD","LU0605514214.HKD","LU0873338254.USD","LU0786609619.USD","LU0642271901.SGD","LU2088747998.USD","IE00B8HQ1Z84.USD","IE0032834883.USD","SG9999006514.SGD","LU2351347302.SGD","LU1993786604.SGD","LU0327786744.USD","LU1226288253.USD","02800","LU0979878070.USD","LU0345769128.USD","LDEM","BK1229","LU2449936058.SGD","00700","LU2498475776.HKD","LU0878004406.USD","LU0210533765.USD","LU0630378429.USD","LU0254981946.USD","SGXZ99366536.SGD","LU0431992006.USD","LU2097828631.EUR","SG9999015986.USD","IE00B5MMRT66.SGD","BK1586","LU1504937902.USD","LU2039709279.SGD","BK1096","07226","601600","HK0000286598.CNH","BK1587","IE00BZ08YR35.GBP","LU0051755006.USD","IE00B0JY6N72.USD","LU1188198961.HKD","LU1051769294.HKD","LU2279858448.HKD","LU0106252389.USD","07552","LU0918141705.HKD","LU1051768304.USD","SG9999003461.SGD","LU0210526637.USD","SG9999002828.SGD","LU0359201612.USD","LU1044874839.SGD","LU0214875030.USD","LU0345775950.USD","LU0516423091.SGD","LU0228659784.USD","03419","HK0001040168.HKD","LU0345769631.USD","LU2045819591.USD","LU0675040207.SGD","LU2237443465.HKD","LU0197773160.USD","LU0541501648.USD","BK1589","IE00BVYPNQ40.USD","LU0140636845.USD","LU0072462343.USD","BK1103","LU1282649067.USD","LU0396098781.USD","SG9999014906.USD","SG9999015945.SGD","LU0828237510.HKD","LU1105468828.SGD","BK1164","LU0543330483.HKD","LU0084288322.USD","LU2488822045.USD","LU0441854154.USD","02837","LU1044876610.USD","LU2476274308.USD","LU1733274390.USD","MIUmain","LU0164872284.USD","LU0516423174.USD","IE0003895053.USD","LU1196710195.USD","LU1226287792.SGD","LU1868837722.USD","BK1542","LU0577902298.EUR","SG9999001051.SGD","LU0449515922.USD","LU0117841782.USD","LU0143863784.USD","LU0229945570.USD","BK1610","IE00BQXX3D17.EUR","LU1439103000.SGD","LU1868838027.USD","LU1497733631.SGD","LU0128522157.USD","HK0000288743.USD","BK1175","IE00BYV24P56.USD","LU0531971595.HKD","BK1570","LU0359202008.SGD","LU0149534421.HKD","LU1719994722.HKD","LU0683595622.HKD","LU0348788117.USD","LU0348825331.USD","LU1282648689.USD","SG9999007991.SGD","03037","LU2357305700.SGD","BK1604","IE00B067MR52.USD","09067","03121","BK1231","HK0000352382.USD","LU1508157978.USD","LU1196710351.USD","LU0203347892.USD","03145","LU0175139822.USD","LU0345776255.USD","LU0823426308.USD","LU1102505929.USD","LU0449509016.USD","LU1883866441.USD","PAImain","LU2424517915.HKD","HK0000914660.USD","LU0417516902.SGD","LU0823040885.USD","PNGAY","IE0003795394.USD","LU0588546209.SGD","LU2348773727.SGD","LU0127658192.USD","00939","IE00BZ08YS42.EUR","LU0985320562.USD","LU0106959298.USD","LU0797268264.HKD","LU2929501877.USD","LU1226288097.SGD","LU0862451837.USD","LU1328615791.USD","LU0345780950.USD","LU0048597586.USD","SG9999010052.SGD","LU2125910849.SGD","SGXZ31699556.SGD","LU2293587155.HKD","LU2106854487.HKD","LU0501845795.SGD","IE00B3M56506.USD","HK0000107257.USD","MCHmain","IE00BMCWC346.EUR","LU0261947096.USD","SG9999001689.USD","GAMR","TCOM","LU0823041008.USD","LU1568876335.HKD","LU0328353924.USD","LU2348774022.SGD","LU0543330566.HKD","LU2294711473.HKD","LU0823038988.USD","BK1550","LU1023057109.AUD","JEMA","LU0509642566.USD","LU0456846285.SGD","LU1880383366.USD","IE00BGV7N243.SGD","LU1814569148.SGD","LU0080751232.USD","LU0039217434.USD","LU1316542783.SGD","LU2251237306.USD","LU0293314216.USD","LU0762541174.USD","LU0819123356.HKD","BK1531","SG9999018865.SGD","ESPO","LU1481107354.HKD","LU1146622755.USD","LU0823397285.USD","LU0871576103.HKD","LU0588545730.USD","LU1568876251.USD","01209","LU2097828714.EUR","BK1506","LU0348827113.USD","LU0345781412.USD","LU0620787316.HKD","LU0054450605.USD","TCEHY","LU0651946864.USD","BK1594","LU1880398471.USD","82800","LU0052750758.USD","BK1240","03067","SGXZ86797644.SGD","LU1251922891.USD","HHImain","07500","LU0588545904.SGD","LU0228367735.SGD","LU0477156797.USD","HK0000306701.USD","LU0791591158.USD","SGXZ51526630.SGD","BABA","BK1557","LU0261950983.USD","LU0082770016.SGD","LU1242518857.USD","BK1516","LU2251237488.HKD","BK1500","02833","03993","LU0320764243.SGD","LU0107464264.USD","LU0488056044.USD","LU0251144936.SGD","LU0531970944.HKD","LU0572944931.SGD","LU0173614495.USD","BK1615","83115","IE0003851619.USD","LU0588545490.SGD","LU0130518102.USD","HK0001040143.USD","LU1868837565.USD","LU1634259391.SGD","03143","LU0882747503.HKD","SG9999015952.SGD","LU0918141887.USD","BK1507","BK1618","09088","LU0348723411.USD","BK1523","IE0008368304.USD","LU0862451753.SGD","LU1115378108.SGD","LU0455707207.USD","LU1770036033.HKD","LU2476274720.SGD","LU0541502299.USD","LU0417516571.SGD","LU0823426480.USD","BK1560","LU0886674414.USD","LU1642822792.SGD","IE00BMPRXR70.SGD","LU2265009873.SGD","IE0009570106.USD","LU1323998911.USD","LU2097828557.USD","HK0000320264.USD","LU0630314457.HKD","LU0269904917.USD","LU0633140727.USD","LU0348784397.USD","HSTECH","LU1166156734.SGD","BK1555","LU1201861165.SGD","LU0878005551.USD","KURE","BK1584","LU1044875133.USD","LU0326948709.USD","LU0326950275.SGD","01093","BK1258","LU1810669033.SGD","LU0164865239.USD","BK1591","LU0289960550.SGD","LU1629966141.USD","LU1152091168.USD","09115","00688","SG9999004311.SGD","EEMX","BK1184","LU0149721374.USD","LU0594300419.USD","HK0000151867.HKD","IE00B0169N27.USD","BK1161","LU2242644610.SGD","LU1242518931.SGD","LU0235996351.USD","LU0329678170.USD","LU0737861772.HKD","LU1224709979.USD","LU0572940350.SGD","LU1235295612.USD","LU2663582299.SGD","03423","89988","LU0096374516.USD","LU0117844026.USD","LU1960683339.HKD","LU2362541513.USD","LU0762540952.USD","HK0000165453.HKD","LU1226288170.HKD","LU2399975544.HKD","IE0008368411.USD","CICHY","LU1064130708.USD","LU0205439572.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664823083","title":"星展銀行上調比亞迪電子目標價至40港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664823083","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664823083?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 11:14","pubTimestamp":1788405278,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1149","BK1515","BK1607","BK1580","BK1504","LU0274383008.USD","BK1589","BK1582","BK1167","LU0348766576.USD","00285","BK1540","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":7,"totalSize":219,"code":"91000000","status":"200"}]}}